Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

ABSTRACT: A multi-center, open-label, extended treatment, clinical trial examining the safety of administering multiple does of panitumumab by intravenous (i.v.) infusion to patients who have previously received panitumumab and benefited from treatment

DISEASE(S): Colorectal Cancer,Non-small Cell Lung Cancer,Carcinoma, Renal Cell,Prostate Cancer,Solid Tumors,Advanced Renal Cell Carcinoma

PROVIDER: 2036361 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR